About
Dr. Colin Lindsay is a Clinical Senior Lecturer in Medical Oncology at the University of Manchester's Division of Cancer Sciences and Honorary Consultant at The Christie NHS Foundation Trust. He earned his PhD at the CRUK Beatson Institute in Glasgow under Professor Owen Sansom, researching RAS/RAF-driven melanoma models. His current work bridges translational lung cancer research and clinical practice.
His research focuses on:
- RAS-driven cancer therapeutics
- Genomic translation for clinical impact
- Non-small cell and small cell lung cancer treatment optimization
- Targeted therapy-radiotherapy combinations
Recent publications (2025) demonstrate strong emphasis on:
- KRAS/EGFR mutation-targeted therapies
- Immuno-oncology mechanisms
- Real-world therapeutic efficacy studies
- Radiotherapy-drug synergies
Awards:
- ESMO Translational Fellowship (Gustave Roussy Institute, France)
He directs the 'Data-driven cancer genome interpretation for personalised cancer treatment' project (2022-2027) and collaborates with Cancer Research UK Manchester Institute, Crick Institute London, and Lydia Becker Institute.
0Publications listed
